Cervical cancer is the second commonest cancer among females in Indonesia. The Global Burden of Disease 2017 study provides the comprehensive estimates of all diseases, including cervical cancer. This study was aimed to give overview of burden of cervical cancer at national and provincial level in Indonesia from 1990 to 2017. This was descriptive study using the GBD 2017 results for cervical cancer incidence, prevalence, deaths, disability-adjusted life-years (DALYs), and risk factors. Cervical cancer incidence in Indonesia rose slightly (17%) from 7.4 to 8.7 per 100,000 women. Prevalence rate rose 20.8% in the same period, from 43.3 to 52.4 per 100,000. Meanwhile, death rate was almost same from, 3.3 and 3.7 per 100.000 respectively. DALYs of cervical cancer increased significantly from 211,616 to 303,308. At provincial level, in 2017 the highest prevalence rate and incidence rate were in North Maluku and West Papua. The lowest were in the North Kalimantan and North Sumatera. Incidence rate and death rate of cervical cancer rose from age of 30-34 and peaked at 95+. Meanwhile, prevalence rate and DALYs rate started at age of 25-29 and steadily high at age of 44. Risk factors contributed to cervical cancer were unsafe sex and tobacco.

Objective: The study aimed to measure achievement of the national program of cervical and breast cancer screening in Indonesia after 12 years implementation and factors associated with the number of the screening. Methods: This was a cross-sectional study with descriptive and analytic analysis. Secondary data was collected from Directorate of Non Communicable Disease Control, Ministry of Health. Results: From 2007 to 2018, the program was implemented in all 34 provinces, at 51% primary health centers (PHC) with 3 providers each. Total women aged 30-50 years screened was 3,664,625 (9.8% of the target). The number rose gradually from 2007 to 2014, with significant increase from 2015 to 2018. Bali province had the highest coverage (31%) and Papua had the lowest (1%). We found a wide disparity of coverage among provinces. There was 3.4% of VIA-positive, 16.1% was treated with cryotherapy, 1.3 per 1,000 of suspected cervical cancer, 5,4% lump in the breast, and 0.7 per 1,000 suspected breast cancer. Factors associated with number of the screening were number of PHC providing screening, number of GP, total provider, number of NCD post, number of Village with NCD Post, and income of the province. Conclusion: The cervical and breast cancer screening program was running in all provinces in more than half of primary health centers in Indonesia. National coverage (9.8%) was far below the target and varied widely among provinces. Number of PHC with screening services, number of GP, number of total provider, number of NCD post, number of Village with NCD Post, and income of the province have association with cervical and breast cancer screening.

Tujuan untuk mengetahui besarnya masalah servisitis dan determinan kejadian servisitis pada peserta Female Cancer programme (FcP) di DKI Jakarta. Metode desain potong lintang dan data sekunder bersumber dari data pemeriksaan IVA Female Cancer programme (FcP) di DKI Jakarta tahun 2017-2019. Jumlah sampel  3378 orang, Variabel-variabel yang diteliti adalah servisitis (dependen), dan sebagai variabel independennya adalah,  metode penggunaan kontrasepsi, paritas, usia, indeks massa tubuh, usia pertama kontak seksual, status merokok, frekuensi menikah responden, frekuensi menikah suami responden, tingkat pendidikan responden, riwayat keguguran. Analisis univariat mendeskripsikan frekuensi dan distribusi dari variabel yang diteliti, analisis bivariat dan multivariat yang digunakan regresi logistik. Hasil penelitian menunjukkan prevalensi servisitis 11,13% dan  faktor-faktor yang berhubungan dengan kejadian servisitis adalah faktor metode penggunaan kontrasepsi  dan faktor usia. Dibandingkan dengan kelompok yang tidak menggunakan alat kontrasepsi, kelompok yang menggunakan metode kontrasepsi hormonal mempunyai prevalen odds kejadian sevisitis 1,593 kali lebih tinggi (POR 1,593; 95% CI 1,244-2,040), sementara pada kelompok yang menggunakan metode kontrasepsi non-hormonal mempunyai prevalen odds kejadian servisitis yang tidak berbeda dengan kelompok yang tidak menggunakan alat kontrasepsi (POR 0,832; 95% CI 0,616-1,22). Dibandingkan dengan kelompok umur >51 tahun, kelompok usia 30-39 mempunyai prevalen odds kejadian servisitis 2,107 kali lebih tinggi (POR 2,017; 95% CI 1,312-3,383), kelompok usia 40-50 tahun mempunyai prevalen odds kejadian servisitis 2,203 kali lebih tinggi (POR 2,203; 95% CI 1,379-3,518). Sementara itu tidak ada perbedaan prevalen odds kejadian servisitis pada kelompok usia <30 dan kelompok usia > 51 tahun. Kesimpulan: Prevalensi servisitis 11,13% dan faktor-faktor determinan terjadinya servistis pada pemeriksaan IVA FcP di DKI Jakarta tahun 2017-2019 adalah faktor metode  kontrasepsi hormonal dan faktor usia